Article
The soluble Y115E-Y117E variant of human glutaminyl cyclase is a valid target for X-ray and NMR screening of inhibitors against Alzheimer disease.
Acta crystallographica. Section F, Structural biology communications - 1 Aug 2015
DiPisa Flavio, Pozzi Cecilia, Benvenuti Manuela, Andreini Matteo, Marconi Guido, Mangani Stefano
Abstract excerpt
Recent developments in molecular pathology and genetics have allowed the identification of human glutaminyl cyclase (hQC) among the abnormal proteins involved in many neurodegenerative disorders. Difficulties in obtaining large quantities of pure protein may limit the use of crystallographic screening for drug development on this target. Site-directed mutagenesis experiments have led to the identification of some...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
